Characteristics Total (n=34)
Age, mean  ±  SD, years 43.05 ± 9.92
Male gender, No (%) 18 (52.95%)
Transplant from living donor 16 (47.05%)
Mean Conversion day after KT, months 29.8 ± 15.0
Mean follow up, months 28.0 ± 4.41
Advagraf dose†, mean  ±  SD, mg 2.56 ± 1.24
Advagraf level†, mean  ±  SD, ng/mL 3.00 ± 0.51
Sirolimus dose†, mean  ±  SD, mg 1.74 ± 0.50
Sirolimus level†, mean  ±  SD, ng/mL 6.64 ± 2.01
All data are expressed as mean ± SD.
†The dose and level of the drugs were measured at 3 months after conversion.
Table 3: The patient’s demographics, mean doses and levels of the Advagraf and sirolimus.